focusing on the development of drug resistant targets, tongnuokang has independently built a series of research platforms based on the combination of artificial intelligence (ai) and multi omics technology (omics). tumor therapy based on synthetic lethal therapy can accurately target cancer cells, and can also accurately screen patients according to their cancer cell gene mutations. in the future, synthetic lethal therapy will play a huge role in tumor precise therapy.